DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 9Dr. Reddy's Laboratories
02 2Breckenridge Pharmaceutical
03 2NanoAlvand
04 2Naprod Life Sciences
05 12Accord healthcare
06 2Accure Labs
07 2Actavis Inc
08 4Alphapharm PTY Ltd
09 3Apotex Inc
10 10Astellas Pharma
11 2Auro Pharma Inc
12 2Aurobindo Pharma Limited
13 1Azurity Pharma
14 1Baxter Healthcare Corporation
15 2Biem Ilac San. ve Tic. A.S
16 5CEPHALON INC
17 3CPS Cito Pharma Services GmbH
18 2Capstone Development Services
19 2CinnaGen Co
20 2EG SpA
21 1EUGIA PHARMA INC.
22 2Eagle Pharmaceuticals
23 2Eriochem S.A.
24 2Fresenius Kabi Oncology Limited
25 1Fresenius Kabi USA
26 1GetWell Pharmaceutical
27 2Glenmark Pharmaceuticals
28 5Hospira, Inc.
29 2Innopharma Inc
30 1Jodas Expoim Pvt. Ltd
31 4Juno Pharmaceuticals Pty Ltd
32 2MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH
33 2Meitheal Pharmaceuticals
34 2NORVIUM BIOSCIENCE
35 2Nang Kuang Pharmaceutical Co. Ltd.
36 1Natco Pharma
37 2Natco Pharma (Canada) Inc
38 1Panacea Biotec Limited
39 1Pfizer Inc
40 1SEACROSS PHARMACEUTICALS
41 1Sakar Healthcare
42 8Sandoz B2B
43 2Teva Pharmaceutical Industries
44 2TherDose Pharma
45 2Vama Lifecare
46 2Viatris
47 1Vinkem Labs Ltd
48 1XYZ Pharma
01 4Bendamustina 100Mg 5 Units Parenteral Use
02 1Bendamustina 25Mg 20 Joined The Parenteral Use
03 4Bendamustina 25Mg 5 Units Parenteral Use
04 8Dry Sub
05 1FREEZE-DRIED POWDER
06 1INJECTABLE; INJECTION
07 4INJECTION
08 1Infusion
09 2Injectable
10 14Injection
11 1Liquid Injection
12 1Lyo.Inj
13 1Lyophilised Injection
14 1Lyophilized Injection
15 2Lyophilized Powder for Solution for Infusion
16 4POI
17 2POWDER FOR CONCENTRATE FOR
18 11POWDER FOR SOLUTION
19 18POWDER;INTRAVENOUS
20 8POWDER;IV (INFUSION)
21 1PULVER TILL KONCENTRAT TILL
22 8Powder to concentrate to the infusion fluid, resolution
23 1SOLUTION
24 11SOLUTION;INTRAVENOUS
25 1SOLUTION;IV (INFUSION)
26 1Trockensub
27 2Vial
28 12Blank
01 11DISCN
02 7Generic
03 1Lead Market Dossiers- Approved in EU
04 4Lead Market Dossiers- Filed
05 2Lead Market Dossiers- Tentative\nApproved in US
06 4Originator
07 17RX
08 80Blank
01 1BELRAPZO
02 31BENDAMUSTINE HYDROCHLORIDE
03 7BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
04 1BENDAWEL
05 1BENDEKA
06 1BENVYON
07 2Beastin
08 1Bendamustin Accord
09 2Bendamustin Actavis
10 6Bendamustina
11 5Bendamustine Accord
12 2Bendamustine Fresenius Kabi
13 4Bendamustine Juno
14 8Bendamustine Sandoz
15 4Bendamustine Viatris
16 4Bendanit
17 2ERIOTIB
18 5Levact
19 2NAT-BENDAMUSTINE
20 3Ribomustin
21 2Ribomustin 100 mg
22 2Ribomustin 25 mg
23 1Ribovact
24 2THERMUSTINE
25 7TREANDA
26 1VIVIMUSTA
27 19Blank
01 2Argentina
02 12Australia
03 12Canada
04 21India
05 4Iran
06 9Italy
07 8Norway
08 4South Africa
09 3Sweden
10 9Switzerland
11 2Turkey
12 39USA
13 1United Kingdom
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date : 2022-12-07
Application Number : 205376
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date : 2023-02-14
Application Number : 205447
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Iran
Brand Name : Bendanit
Dosage Form : Vial
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilised Injection
Dosage Strength : 100MG/Vial
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2022-12-07
Application Number : 205376
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 45MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 25MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in EU
Registration Country : India
Brand Name :
Dosage Form : Infusion
Dosage Strength : 180MG/4ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in EU
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2023-02-14
Application Number : 205447
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Iran
Brand Name : Bendanit
Dosage Form : Vial
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Liquid Injection
Dosage Strength : 90MG/ML
Packaging : 0.5 ml and 2 ml pack
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date : 2023-06-05
Application Number : 204230
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2023-06-05
Application Number : 204230
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TREANDA
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2008-03-20
Application Number : 22249
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TREANDA
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date : 2009-05-01
Application Number : 22249
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TREANDA
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 45MG/0.5ML (90MG/ML)
Packaging :
Approval Date : 2013-09-13
Application Number : 22249
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TREANDA
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 180MG/2ML (90MG/ML)
Packaging :
Approval Date : 2013-09-13
Application Number : 22249
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : TREANDA
Dosage Form : INJECTABLE; INJECTION
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 22303
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;IV (INFUSION)
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date :
Application Number : 204771
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;IV (INFUSION)
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date :
Application Number : 204771
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;IV (INFUSION)
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date :
Application Number : 204086
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;IV (INFUSION)
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date :
Application Number : 204086
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;IV (INFUSION)
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date :
Application Number : 205476
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;IV (INFUSION)
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date :
Application Number : 205476
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date : 2023-04-28
Application Number : 204104
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2023-04-28
Application Number : 204104
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?